Launch of New GMP Oligo Manufacturing Facility
Eurofins Genomics US Expands Capabilities with New GMP Oligonucleotide Manufacturing Facility
READ THIS
Eurofins Genomics Launches AAV Sequencing
7/16/24 | 5 Min Read
Eurofins Genomics now offers affordable, fast AAV sequencing using the Oxford Nanopore (ONT) sequencing platform, which is known for providing real-time, long-read sequencing. Traditional sequencing methods often struggle with the repetitive and GC-rich regions of AAV genomes, whereas ONT traverses these complexities, ensuring complete and accurate genome assemblies.
READ THIS
Eurofins Genomics US Extends Service Offering for Nanopore Sequencing with Bacterial Genome Sequencing
12/18/23 l 5 min read
Bacterial Genome sequencing is designed for the comprehensive analysis of entire genomes. It involves the sequencing and assembly of genomic DNA (gDNA) derived from a clonal population, specifically a singular bacterial species. Leveraging cutting-edge long-read sequencing technology from Oxford Nanopore Technologies (ONT), this service encompasses the following key components:
READ THIS
Eurofins Genomics US Adds Amplicon Sequencing to ONT Service Portfolio
11/11/23 l 5 min read
Amplicon sequencing, a technique focused on the targeted amplification of specific DNA regions, benefits significantly from the long-read capabilities of Oxford Nanopore sequencing. Unlike short-read technologies, such as those based on Illumina platforms, Oxford Nanopore sequencing generates reads of exceptional length. This feature is particularly advantageous for amplicon sequencing, as it enables the sequencing of entire target regions in a single, contiguous read.
READ THIS
Nanopore Sequencing Service | Fast & Accurate Results
02/09/23 | 5 Min Read
Eurofins Genomics US, the global leader in sequencing, launches a revolutionary new, low cost, whole plasmid sequencing service with same-day results. The company expanded its already massive sequencing infrastructure in Louisville to include Nanopore sequencing capabilities.
READ THIS
Eurofins Announces Partnership with Ginkgo Bioworks for Innovative SARS-CoV-2 Waste Water Testing in U.S. Airports
02/10/23 | 10 Min Read
Eurofins Genomics has partnered with Concentric by Ginkgo Bioworks on an expanded program that will serve as an early warning system to detect new or emerging SARS-CoV-2 variants, and can facilitate response to future travel-associated outbreaks and pandemics. It provides a pulse of COVID-19 cases and the arrival of variants among international travelers, delivering important data as the country monitors the global COVID-19 situation.
READ THIS
DAF Awards $30 Million Contract to Eurofins Genomics to Expand Oligonucleotide (DNA) Capacity for Diagnostic Testing
10/08/21 | 4 Min Read
The Department of Air Force, in coordination with the Department of Health and Human Services (HHS), awarded a $30 million contract to Eurofins Genomics US to build a new production facility and expanded capacity for the manufacturing of reagents used in COVID-19 diagnostic tests.
READ THIS